Attendees 参会企业

Thero天英汇总决赛—广州费米子科技有限责任公司


项目名称:基于数据和算法驱动的临床前小分子新药研发平台

广州费米子科技有限责任公司是一家AI驱动的创新药物发现企业,通过AI技术提高药物研发阶段的研发效率,在PCC与IND阶段与药企进行合作或转让,获得现金及药物长期权益回报。费米子公司研发团队目前主要研发目标产品是AI药物研发平台。在云计算和专用超级计算机的帮助下,AI制药平台通过穷尽所有靶点数据库找到靶点,运用云端计算和算法精准预测,快速筛选活性化合物,虚拟构建药物分子,缩短研发周期,从而提升研发过程的效率,降低新药研发成本,降低后续药物临床试验的失败概率。

公司在2020年完成A+轮融资,累计上亿元A轮融资,本轮投资方包括熊猫资本、广州金控、同晟资本等,团队之前获挑战者资本领投,熊猫资本跟投Pre-A轮融资。

Fermion is a company focusing on innovative drugs discovery by AI technology. The profit of our business is mainly based on cooperation with pharmaceutical companies during PCC and IND stages. With the participating of cloud-computing and supercomputers, our AI technology is able to discover the suitable targets, screen and model the active pharmaceutical molecules, which can improve the efficiency of R&D process and lower the risk of failure during clinical trials. Comparing to the traditional drug discovery, our process is much efficient and economic.

Fermion has achieved series A+ financing in November 2020. Investors includes Panda Capital, Tong Sheng Capital and Guangzhou Finance Holding Group etc. In December 2018, our series pre-A financing was achieved by the leading investment of the Challenjers and Panda Capital.


Contact Us

For more information, please contact at
Email: gzinnofestival@163.com
Telephone: 8620-83366321

如需更多信息和查询,请联系
官方邮箱:gzinnofestival@163.com
联系电话:8620-83366321

网站备案号:粤ICP备13032278号-2   技术支持:ASE Solution Company